secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2022-07-27T23:59:59+00:00
Accession:  0001558370-22-011140
Event type: earnings
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health reports Q2 revenue $592M (+18% YoY) but net loss $3.1B on $3.0B goodwill impairment
--------------------------------------------------------------------------------

- Revenue $592.4M (+18% YoY); net loss per share $19.22, mainly from $3.0B non-cash goodwill impairment.
- Adjusted EBITDA $46.7M, down 30% YoY from $66.8M.
- CEO Jason Gorevic cited solid results and Primary360 momentum but noted macroeconomic uncertainty.
- Six-month revenue $1.16B (+21% YoY); net loss $9.78B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/0001558370-22-011140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/tdoc-20220727x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-011140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer